Portman Square Capital’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.29M | Buy |
145,693
+6,446
| +5% | +$278K | 0.18% | 19 |
|
|
2025
Q1 | $4.81M | Buy |
139,247
+114,720
| +468% | +$3.97M | 0.13% | 19 |
|
|
2024
Q4 | $673K | Sell |
24,527
-52,760
| -68% | -$1.45M | 0.02% | 42 |
|
|
2024
Q3 | $1.97M | Buy |
77,287
+29,110
| +60% | +$741K | 0.07% | 28 |
|
|
2024
Q2 | $1.22M | Sell |
48,177
-29,453
| -38% | -$746K | 0.04% | 45 |
|
|
2024
Q1 | $2.4M | Buy |
77,630
+49,951
| +180% | +$1.54M | 0.07% | 14 |
|
|
2023
Q4 | $1.12M | Sell |
27,679
-192,918
| -87% | -$7.79M | 0.03% | 47 |
|
|
2023
Q3 | $5.82M | Buy |
+220,597
| New | +$5.82M | 0.14% | 25 |
|